BWX Technologies

The latest read

Computed from the data on Oct 23, 2026. Every figure links back to its source in the sections below.

• Revenue over the four quarters to June 30, 2026: $3.51 billion, up 23% from a year earlier.SEC EDGAR filings (XBRL)
• Free cash flow (operating cash flow minus capital expenditure) over the four quarters to June 30, 2026: $0.32 billion, down 11% from a year earlier.SEC EDGAR filings (XBRL)
• Capital expenditure over the four quarters to June 30, 2026: $0.20 billion, up 25% from a year earlier.SEC EDGAR filings (XBRL)
• Share buybacks in the fiscal year to December 31, 2025: $0.03 billion.SEC EDGAR filings (10-K)
• Long-term debt issued in the fiscal year to December 31, 2024: $0.46 billion.SEC EDGAR filings (10-K)
• Latest earnings call or results release (August 3, 2026): sentiment 0.40 on a −1 to +1 scale (mixed), confidence 0.80 of 1.Palanor Discourse
• Guidance in the last 90 days: 4 outlook figures raised, 0 lowered, 0 held.Guidance Ledger (8-K results releases)
• Latest annual report (filed February 23, 2026): 0 risk factors added, 1 removed.Risk Factor Changes (10-K Item 1A)
• Insiders were net sellers in Q3 2026: $1.7 million on the open market.SEC Form 4
• 854 institutional managers reported a position at June 30, 2026 (+23 on the quarter before).SEC Form 13F
• H-1B filings certified in Q2 2026: 1.U.S. Department of Labor (OFLC)

Company Posture covers S&P 500 companies.

No bond term sheets or tagged debt on file for BWX Technologies yet.

BWX Technologies's rows in Palanor's event trackers over the last three years, its own and its subsidiaries': FDA decisions, deal filings, IPO filings, private raises, insider clusters and 13D stakes, and distress filings. Each links to its filing or FDA record.

Records as filed. An FDA date is the agency's goal date; a filing records a step or an event, not what follows. Nothing here is a forecast or advice.

Charts

Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.

In the news

Headlines that name BWX Technologies, with the publisher and a link. The tone is read from each headline’s own words, never from a summary of the article.

30 days

3 headlines

33% positive · 0% negative

90 days

3 headlines

33% positive · 0% negative

• Neutral
  BWX Technologies: This Nuclear Growth Engine Is Still Underestimated (NYSE:BWXT)

  seekingalpha.com · via Marketaux · Oct 5, 2026

• Neutral
  Jim Cramer Weighs In on BWX Technologies After 27% Pullback

  insidermonkey.com · via Marketaux · Oct 4, 2026

• Positive
  BWX Technologies (BWXT) Secures $189 Million Naval Nuclear Fuel Contract

  gurufocus.com · via Marketaux · Oct 1, 2026

Filings and records

The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.

1. Oct 20, 2026Patent
   Patent granted: FUEL BUNDLE WITH TWISTED RIBBON FUEL RODLETS FOR NUCLEAR THERMAL PROPULSION APPLICATIONS, STRUCTURES FOR MANUFACTURE, AND METHODS OF MANUFACTUREUS 12770747
2. Oct 19, 2026Lobbying
   Lobbying report (STRATEGIC MARKETING INNOVATIONS)third_quarter 2026 · $0.0 million
3. Oct 19, 2026Lobbying
   Lobbying report (WILLIAMS AND JENSEN, PLLC)third_quarter 2026 · $0.0 million
4. Oct 19, 2026Lobbying
   Lobbying report (STRATEGIC MARKETING INNOVATIONS)third_quarter 2026
5. Oct 17, 2026Lobbying
   Lobbying report (VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC))third_quarter 2026 · $0.1 million
6. Oct 14, 2026Lobbying
   Lobbying report (BWX TECHNOLOGIES, INC.)third_quarter 2026 · $0.2 million
7. Oct 13, 2026Patent
   Patent granted: System and Method for Multi-spot Beam TrackingUS 12762861
8. Sep 8, 2026Patent
   Patent granted: HEAT PIPE FUEL ELEMENT AND FISSION REACTOR INCORPORATING SAME, PARTICULARLY HAVING PHYLLOTAXIS SPACING PATTERN OF HEAT PIPE FUEL ELEMENTS, AND METHOD OF MANUFACTUREUS 12731700
9. Aug 11, 2026Patent
   Patent granted: SYSTEM AND METHOD FOR PARTICLE MORPHOLOGY CLASSIFICATIONUS 12705307
10. Jul 20, 2026Lobbying
    Lobbying report (WILLIAMS AND JENSEN, PLLC)second_quarter 2026 · $0.0 million
11. Jul 17, 2026Lobbying
    Lobbying report (VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC))second_quarter 2026 · $0.1 million
12. Jul 13, 2026Lobbying
    Lobbying report (BWX TECHNOLOGIES, INC.)second_quarter 2026 · $0.2 million
13. Jun 23, 2026Patent
    Patent granted: METHOD FOR DETERMINATION OF ACTINIUM-227 IN ACTINIUM-225US 12663551
14. May 5, 20268-K
    Shareholder vote resultsItem 5.07
15. Feb 23, 202610-K
    Annual report (10-K)0 risk factors added, 1 removed
16. Feb 20, 20268-K
    Director or officer changeItem 5.02
17. Nov 10, 20258-K
    Material agreement signedItem 1.01
18. Nov 4, 20258-K
    Director or officer changeItem 5.02
19. Jun 16, 20258-K
    Director or officer changeItem 5.02
20. May 12, 20258-K
    Director or officer changeItem 5.02
21. May 8, 20258-K
    Director or officer changeItem 5.02
22. May 7, 20258-K
    Shareholder vote resultsItem 5.07
23. Feb 24, 202510-K
    Annual report (10-K)1 risk factors added, 0 removed
24. Jan 10, 20258-K
    Director or officer changeItem 5.02
25. Feb 27, 202410-K
    Annual report (10-K)1 risk factors added, 0 removed

Peers

Companies in the same sector in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.

Identity

SEC CIK

1486957

LEI

549300NP85N265KWMS58

Wikidata

Q4836852